Le Lézard
Classified in: Health
Subject: SVY

Global Psoriasis Partnering 2010 to 2017


LONDON, Nov. 16, 2017 /PRNewswire/ -- The Global Psoriasis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

Download the full report: https://www.reportbuyer.com/product/3605692

? Trends in partnering deals
? Top deals by value
? Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered ? contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2010 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2010 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Download the full report: https://www.reportbuyer.com/product/3605692

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 08:53
Voiant (USA) and Thirona (The Netherlands) are pleased to announce they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in...

at 08:51
In a move that is set to transform clinical reproductive medicine, GenEmbryomics Limited, a pioneering provider of advanced genetic testing services for embryos, and Progenesis Inc, a leading provider of preimplantation genetic testing for in vitro...

at 08:48
For the eighth year in a row, the VIN Foundation, a 501(c)(3) nonprofit, has earned the Platinum Seal of Transparency from Candid. This highest level of recognition from Candid, the world's largest source of information on nonprofit organizations,...

at 08:46
Autism Digest, a cornerstone in the autism community, is thrilled to announce a series of celebratory initiatives as part of its significant 25th anniversary milestone. As a leader in providing insightful content for those affected by autism, Autism...

at 08:46
Midi Health, the fastest-growing virtual care clinic for women navigating perimenopause and menopause, today announced the close of a $60M Series B funding round led by Emerson Collective, bringing the company's total funding raised to date to $100M....

at 08:44
Hire Health, a healthcare-focused human capital solutions firm, announced its official launch today. With a passion for improving patient care and commitment to optimal business outcomes, Hire Health is uniquely positioned to assist healthcare and...



News published on and distributed by: